scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PLoSO...9j0127X |
P356 | DOI | 10.1371/JOURNAL.PONE.0100127 |
P932 | PMC publication ID | 4069059 |
P698 | PubMed publication ID | 24959694 |
P5875 | ResearchGate publication ID | 263397273 |
P50 | author | Lin Zhang | Q50942251 |
P2093 | author name string | Yang Xu | |
Fang Liu | |||
Qimin Zhan | |||
Nan Zhao | |||
Xiaohang Zhao | |||
Lanping Zhou | |||
Zhengwei Lin | |||
Zbigniew Cichacz | |||
P2860 | cites work | Global cancer statistics | Q22241238 |
Hallmarks of Cancer: The Next Generation | Q22252312 | ||
The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis | Q24293754 | ||
RIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosis | Q24299986 | ||
Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase | Q24302381 | ||
Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha | Q24338113 | ||
Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation | Q24338129 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
Global cancer statistics, 2002 | Q27860562 | ||
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
RIP1, a kinase on the crossroads of a cell's decision to live or die | Q28288337 | ||
The inhibition of autophagy sensitises colon cancer cells with wild-type p53 but not mutant p53 to topotecan treatment | Q28483781 | ||
TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members | Q28505598 | ||
RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis | Q28594624 | ||
Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling | Q28681792 | ||
Molecular mechanisms of necroptosis: an ordered cellular explosion | Q29616004 | ||
Identification of RIP1 kinase as a specific cellular target of necrostatins | Q29616006 | ||
RIP3 mediates the embryonic lethality of caspase-8-deficient mice | Q29617723 | ||
Molecular mechanisms of caspase regulation during apoptosis | Q29617861 | ||
Cellular processing of platinum anticancer drugs | Q29617899 | ||
Is cisplatin-induced cell death always produced by apoptosis? | Q34190171 | ||
Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis | Q34197341 | ||
Signal transduction by tumor necrosis factor and its relatives | Q34341941 | ||
Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway | Q34910947 | ||
Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways | Q35060995 | ||
FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. | Q52614520 | ||
TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. | Q53923667 | ||
A role of RIP3-mediated macrophage necrosis in atherosclerosis development. | Q54456086 | ||
Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significance | Q77553809 | ||
Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis | Q82070785 | ||
Use of mixture models in a microarray-based screening procedure for detecting differentially represented yeast mutants | Q83218424 | ||
Relationship between hypermethylated MGMT gene and osteosarcoma necrosis rate after chemotherapy | Q83674442 | ||
Necrotic concentrations of cisplatin activate the apoptotic machinery but inhibit effector caspases and interfere with the execution of apoptosis | Q83993352 | ||
zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFα mediated by the PKC-MAPKs-AP-1 pathway. | Q35092587 | ||
Overview of cell death signaling pathways | Q36051647 | ||
Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury | Q36774034 | ||
Differential regulation of c-Jun protein plays an instrumental role in chemoresistance of cancer cells. | Q37000508 | ||
Shift from apoptotic to necrotic cell death during human papillomavirus-induced transformation of keratinocytes | Q37160973 | ||
Anti-apoptotic effects of protein kinase C-delta and c-fos in cisplatin-treated thyroid cells. | Q37230815 | ||
RIP kinases at the crossroads of cell death and survival | Q37562142 | ||
Isolation, characterisation and reconstitution of cell death signalling complexes | Q39181693 | ||
Smac mimetic LBW242 sensitizes XIAP-overexpressing neuroblastoma cells for TNF-α-independent apoptosis | Q39366581 | ||
Role of Smac in determining the chemotherapeutic response of esophageal squamous cell carcinoma. | Q39523911 | ||
Inhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cells | Q40028312 | ||
Characterization of 21 newly established esophageal cancer cell lines | Q41643714 | ||
Involvement of high mobility group B proteins in cisplatin-induced cytotoxicity in squamous cell carcinoma of skin. | Q42163245 | ||
Heme induces programmed necrosis on macrophages through autocrine TNF and ROS production. | Q42176313 | ||
Esophageal cancer chemotherapy: recent advances. | Q43194164 | ||
RIP kinases initiate programmed necrosis | Q43292317 | ||
Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas | Q43658477 | ||
Roles of necrosis, Apoptosis, and mitochondrial dysfunction in S-(1,2-dichlorovinyl)-L-cysteine sulfoxide-induced cytotoxicity in primary cultures of human renal proximal tubular cells | Q44355522 | ||
The immediate early genes, c-fos, c-jun and AP-1, are early markers of platinum analogue toxicity in human proximal tubular cell primary cultures | Q46042108 | ||
Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas. | Q48352434 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | esophageal squamous cell carcinoma | Q108442577 |
P304 | page(s) | e100127 | |
P577 | publication date | 2014-06-24 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Receptor interactive protein kinase 3 promotes Cisplatin-triggered necrosis in apoptosis-resistant esophageal squamous cell carcinoma cells | |
P478 | volume | 9 |
Q28608321 | A Role for Tubular Necroptosis in Cisplatin-Induced AKI |
Q34216262 | A prolyl-hydroxylase inhibitor, ethyl-3,4-dihydroxybenzoate, induces cell autophagy and apoptosis in esophageal squamous cell carcinoma cells via up-regulation of BNIP3 and N-myc downstream-regulated gene-1 |
Q38799139 | Cancer and necroptosis: friend or foe? |
Q49679681 | Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies |
Q57809694 | Comparing the effects of different cell death programs in tumor progression and immunotherapy |
Q61814274 | Differential Mechanisms of Cell Death Induced by HDAC Inhibitor SAHA and MDM2 Inhibitor RG7388 in MCF-7 Cells |
Q92645074 | Effect of the conditional knockout of bone marrow specific RIPK3 gene on bone marrow hematopoiesis in mice |
Q61814602 | Glutathione S-transferase Pi 1 is a valuable predictor for cancer drug resistance in esophageal squamous cell carcinoma |
Q96577214 | Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells |
Q37282991 | NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway |
Q39398933 | Necroptosis in cancer: An angel or a demon? |
Q26739959 | Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy |
Q36880241 | Necroptosis: an alternative cell death program defending against cancer. |
Q36210899 | YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice |
Search more.